Interview with Tim Rolfe Risk-based monitoring plays an increasingly important role for clinical trials. Of course, the assessment of the risk is based on statistics. This presents now only interesting career options for statisticians, but also has an impact on the role of statisticians in study teams. In this episode, we’ll give you an introduction …
What you should know about risk-based monitoring! Read More »
Today we’re answering a question from the listeners. As nearly everybody will need to train non-statisticians sooner or later, this is a relevant topic. Unfortunately, lots of the trainings fall short and leave the audience confused and even bored. This episode helps you to make your training engaging, interesting and useful. Such a training will …
How to train non-statisticians effectively – 11 tips to succeed Read More »
Interview with Brett Hauber Ultimately, we work to improve patients lives but traditionally the voice of the patient was not important. However, over the last decades many stakeholders shift to include the patient more in the decision-making process and patients voice their needs and preferences more. Still capturing and evaluating patient preferences does not belong …
What aspects to consider? Are you early in your career and you could still go for a PhD in statistics? Do you wonder, if this pays out short and long-term? Is it worth the money? What are the long-term benefits or are there actually short term benefits as well?
Interview with Oliver Schoenborn-Kellenberger Do you want to change your job?Are you just looking for you first job?Do you consider to work for your own company or as a free-lancer? Then this episode will help you!
Interview with Maria Costa and Shahrul Mt-Isa Benefit-risk assessments are made by various stakeholders including sponsors, regulators, payers, physicians, and patients throughout the life-cycle of a treatment. The understanding of data plays a vital role in weighting positive and negative effects of medications. In this episode, we give you an introduction to what benefit-risk (BR) …